Thom Tillis sold Balchem Corporation (NASDAQ: BCPC)
Thom Tillis (R-NC), a U.S. Senator, has disclosed 1 trade in Balchem Corporation (BCPC) since 2015, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Thom Tillis sold $1,001 - $15,000 of Balchem Corporation (NASDAQ: BCPC) on February 13, 2015. Since that trade, BCPC is up +197.26% against the S&P 500 up +326.94%, an outperformance of -129.67%.
Data updated
Thom Tillis's BCPC trades vs the price
BCPC is up +197.26% since Thom Tillis sold on February 13, 2015, versus +326.94% for the S&P 500.
Performance since this trade
All Thom Tillis BCPC trades
Thom Tillis & BCPC trading FAQ
Is it legal for Thom Tillis to trade Balchem Corporation (BCPC) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Balchem Corporation (BCPC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thom Tillis sell BCPC?
Thom Tillis disclosed a sale of $1,001 - $15,000 of Balchem Corporation (BCPC) on February 13, 2015, according to public STOCK Act filings.
How has BCPC performed since Thom Tillis's trade?
Since Thom Tillis sold BCPC on February 13, 2015, the stock is up +197.26%, versus +326.94% for the S&P 500 over the same period, an outperformance of -129.67%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BCPC trades?
Quantellect tracks every disclosed congressional trade in Balchem Corporation (BCPC) on the Balchem Corporation congressional trading page, which aggregates filings across all members of Congress.
Thom Tillis's BCPC tradesAll congressional filings for Balchem CorporationThom Tillis's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.